设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2022 年第 3 期 第 17 卷

乳腺癌的中医药防治现状及展望

Current situation and prospect of traditional Chinese medicine in prevention and treatment of breast cancer

作者:卢雯平卓至丽

英文作者:Lu Wenping Zhuo Zhili

单位:中国中医科学院广安门医院肿瘤科,北京100053

英文单位:Department of Oncology Guang′anmen Hospital China Academy of Chinese Medical Sciences Beijing 100053 China

关键词:乳腺癌;中医防治;分型-分阶段治疗

英文关键词:Breastcancer;TraditionalChinesemedicinepreventionandtreatment;Classification-stagingtherapy

  • 摘要:
  • 乳腺癌为我国乃至全球女性发病率最高的恶性肿瘤,其死亡人数亦居全球女性癌症死亡人数首位,是国家肿瘤防治的重点。据数据显示2020年全球乳腺癌新发病例高达226万例,中国乳腺癌新发病例数42万例,为中国女性癌症新发病例数之首,占整体女性恶性肿瘤的19.9%。随着医学诊疗技术的发展,中医辨证论治与现代医学精准治疗相结合,乳腺癌的病死率逐渐下降,5年生存率明显提高,已超过83%,与发达国家诊疗水平相当。中医药基于分型-分阶段个体化治疗的指导下,以肿瘤全方位全周期管理为策略,在乳腺癌相关并发症的治疗、复发转移的预防等方面发挥着重要作用。本文从循证医学证据的基础上论述中医药治疗乳腺癌的现状和方法并展望,为临床治疗提供思路。

  • Breast cancer is the malignant tumor with the highest incidence in women in China and even in the world, and its death toll ranks the first in the world. It is the focus of national cancer prevention and treatment. Data showed that in 2020, the number of new cases of breast cancer worldwide reached 2.26 million, and the number in China was 420 thousand. It was the first new incidence of female tumor and accounted for 19.9% of female malignant tumors. With the development of medical diagnosis and treatment technology, the combination of traditional Chinese medicine TCMsyndrome differentiation and treatment with modern medicine, the mortality rate of breast cancer has gradually decreased, the 5-year survival rate has increased significantly, more than 83%, and has been equivalent to developed countries. By classification-staging individualized therapy and strategy of comprehensive cycle management of tumor, TCM plays an important role in the treatment of breast cancer-related complications, the prevention of recurrence and metastasis, etc. Based on the evidence of evidence-based medicine, this paper discusses the current situation and methods of traditional Chinese medicine in the treatment of breast cancer, and makes a prospect, so as to provide ideas for clinical treatment.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭